268 related articles for article (PubMed ID: 29135436)
1. Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis.
Grünewald B; Lange MD; Werner C; O'Leary A; Weishaupt A; Popp S; Pearce DA; Wiendl H; Reif A; Pape HC; Toyka KV; Sommer C; Geis C
Elife; 2017 Nov; 6():. PubMed ID: 29135436
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
Burkovetskaya M; Karpuk N; Kielian T
Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.
Weimer JM; Benedict JW; Getty AL; Pontikis CC; Lim MJ; Cooper JD; Pearce DA
Brain Res; 2009 Apr; 1266():93-107. PubMed ID: 19230832
[TBL] [Abstract][Full Text] [Related]
4. Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease.
Studniarczyk D; Needham EL; Mitchison HM; Farrant M; Cull-Candy SG
eNeuro; 2018; 5(2):. PubMed ID: 29780879
[TBL] [Abstract][Full Text] [Related]
5. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
6. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
[TBL] [Abstract][Full Text] [Related]
7. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
[TBL] [Abstract][Full Text] [Related]
8. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD
Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969
[TBL] [Abstract][Full Text] [Related]
9. Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis.
Weimer JM; Benedict JW; Elshatory YM; Short DW; Ramirez-Montealegre D; Ryan DA; Alexander NA; Federoff HJ; Cooper JD; Pearce DA
Brain Res; 2007 Aug; 1162():98-112. PubMed ID: 17617387
[TBL] [Abstract][Full Text] [Related]
10. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
[TBL] [Abstract][Full Text] [Related]
11. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments.
Luiro K; Kopra O; Blom T; Gentile M; Mitchison HM; Hovatta I; Törnquist K; Jalanko A
J Neurosci Res; 2006 Oct; 84(5):1124-38. PubMed ID: 16941499
[TBL] [Abstract][Full Text] [Related]
12. Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease.
Brooks AI; Chattopadhyay S; Mitchison HM; Nussbaum RL; Pearce DA
Mol Genet Metab; 2003 Jan; 78(1):17-30. PubMed ID: 12559844
[TBL] [Abstract][Full Text] [Related]
13. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
Kühl TG; Dihanich S; Wong AM; Cooper JD
J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.
Katz ML; Johnson GS; Tullis GE; Lei B
Neurobiol Dis; 2008 Feb; 29(2):242-53. PubMed ID: 17962032
[TBL] [Abstract][Full Text] [Related]
15. Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.
Kriscenski-Perry E; Applegate CD; Serour A; Mhyre TR; Leonardo CC; Pearce DA
Epilepsia; 2002 Oct; 43(10):1137-40. PubMed ID: 12366726
[TBL] [Abstract][Full Text] [Related]
16. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
Drack AV; Miller JN; Pearce DA
J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
[TBL] [Abstract][Full Text] [Related]
17. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.
Kovács AD; Saje A; Wong A; Ramji S; Cooper JD; Pearce DA
Neuropharmacology; 2012 Oct; 63(5):769-75. PubMed ID: 22683643
[TBL] [Abstract][Full Text] [Related]
19. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
20. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
Chan CH; Ramirez-Montealegre D; Pearce DA
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]